It started when members of his team, Delaine Ceholski and Cathy Trieber, discovered a new mutation in a protein called phospholamban, which they predicted would cause the heart to be less responsive to changes in the body and eventually lead to heart failure. One month after submitting their paper to the Journal of Biological...
In order to view the entire article, please read your options to the right
If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.
If you are new to NewsRx, you may also take advantage of cost-saving options such as those below to view this article.
View an unlimited number of articles for a day, week, month, etc.
Purchase a bundle of article-viewing-credits that never expire and receive a discount of up to 50%!
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.